Skip to content
Disclosery

EXANE DERIVATIVES: AAL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AAL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 35 AAL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 35 shares
    Change vs previous 13F -7,026 shares

    <0.01% of the 13F portfolio, value $444.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 7,061 shares
    Change vs previous 13F -46,127 shares

    0.04% of the 13F portfolio, value $128,854.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 53,188 shares
    Change vs previous 13F +53,188 shares

    0.23% of the 13F portfolio, value $955,209.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-03-31
    13F 0 shares
    Change vs previous 13F -17,856 shares

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2020-12-31
    13F 17,856 shares
    Change vs previous 13F +2,606 shares

    0.09% of the 13F portfolio, value $281,571.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-09-30
    13F/A 15,250 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $187,428.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).